Russian scientists created an anti-cancer vaccine that significantly prolongs patient’s life. Experts from the Scientific Research Institute of Immunology at the Siberian department of the Russian Academy created a vaccine that successfully passed all clinical researches and showed good results.
The patients receive the vaccine in the third or fourth stage of the disease, prolonging their life for more than two times.
The next phase includes applying the vaccine in the early stages, reports the Voice of Russia.
“When the vaccine was first given to patients in the third or fourth stage of diseases like prostate and breast cancer, the treatment significantly prolonged their life”, says Vladimir Kozlov, leader of the research conducted at the Institute of immunology.
Vaccine is used in the treatment of different cancer types, including: colon, breast and prostate cancer. According to the report of the Institute, the vaccine is ready for commercial production.